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E-mail address: wbaehr@hsc.utah.edu (W. Baehr).The GUCA1A gene encodes a guanylate cyclase activating protein (GCAP1) that is involved in regulation of
phototransduction in the vertebrate retina. We discovered a novel C312A transversion in exon 2 of the
human GUCA1A gene, replacing Asn-104 (N104) in GCAP1 with Lys (K), in two affected members of a fam-
ily with dominant cone dystrophy. The mutation N104K is located in the third EF-hand motif (EF3) shown
previously to be instrumental in converting Ca2+-free GCAP1 to a GC inhibitor in the Ca2+-bound form. In
one patient, rod ERGs were fairly stable over a 12-year-period whereas 30 Hz ﬂicker ERG and single-ﬂash
cone ERGs declined. In both patients, double-ﬂash ERGs showed that rod recovery from an intense test
ﬂash was signiﬁcantly delayed. The EC50 for GC stimulation shifted from 250 nM in wild-type GCAP1
to 800 nM in the GCAP1(N104K) mutant suggesting inability of the mutant to assume an inactive form
under physiological conditions. The replacement of N104 by K in GCAP1 is the ﬁrst naturally occurring
mutation identiﬁed in the EF3 loop. The rod recovery delays observed in double-ﬂash ERG of affected
patients suggest a novel dominant-negative effect that slows GC stimulation.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Photoreceptors, using a process termed phototransduction,
receive light and generate an electrical impulse that is sent to
the visual cortex (Burns & Arshavsky, 2005; Ridge, Abdulaev,
Sousa, & Palczewski, 2003; Stephen, Filipek, Palczewski, & Sousa,
2008). Key events in phototransduction are the hydrolysis of cGMP,
the secondary messenger of phototransduction, and closure of
cGMP-gated cation channels (Polans, Baehr, & Palczewski, 1996).
Channel closure triggers a change in free [Ca2+] (Nakatani, Chen,
Yau, & Koutalos, 2002; Pugh, Nikonov, & Lamb, 1999) and re-syn-
thesis of cGMP by membrane-associated guanylate cyclases (GCs)
present in rod and cone outer segments (Baehr et al., 2007).
Changes in cytoplasmic [Ca2+] are monitored by GC-activating pro-
teins (GCAPs) which are Ca2+-binding proteins of the calmodulin
superfamily (Palczewski, Sokal, & Baehr, 2004). Conformations of
GCAPs change in response to Ca2+ binding. In dark-adapted outer
segments, free Ca2+ is controlled by a light-insensitive NCKX andll rights reserved.
logy, University of Utah, Saltthe cGMP-gated channel, and adjusts to about 250–600 nM
(Woodruff et al., 2007). Under these conditions, high afﬁnity
Ca2+-binding sites (EF-hands) on GCAPs are saturated, GCAPs are
inactive and the GCs display a low basal activity (Gorczyca,
Gray-Keller, Detwiler, & Palczewski, 1994a). In response to light,
free [Ca2+] drops to less than 50 nM, Ca2+ dissociates from Ca2+-
binding sites, and GCAPs convert into activators accelerating cGMP
synthesis roughly 8- and 10-fold.
GCAPs are N-myristoylated neuronal Ca2+ sensors in which the
acyl side chain is buried in the Ca2+-bound as well as the Ca2+-free
state (Stephen, Bereta, Golczak, Palczewski, & Sousa, 2007). A hall-
mark of the GCAP structure are high afﬁnity Ca2+-binding sites
termed EF-hands (Falke, Drake, Hazard, & Peerson, 1994; Gifford,
Walsh, & Vogel, 2007; Persechini, Moncrief, & Kretsinger, 1989)
consisting of a helix-loop-helix secondary structure that is able to
chelate Ca2+ ions. EF-hands also have afﬁnity for Mg2+ ions but the
interaction is several orders of magnitude weaker (Gifford et al.,
2007). In the canonical EF-hand, the loop consists of 12 amino acids
rich in acidic residues providing oxygen ligands for Ca2+ coordina-
tion. The loop is ﬂanked by hydrophobic residues (I, L, Y, W). GCAPs
have two pairs of EF-hands, one each in the N-terminal and C-termi-
nal half of themolecule. The ﬁrst EF-hand in theN-terminal region is
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side chains providing oxygen for Ca2+ coordination (Palczewski et
al., 2004). TheN-terminal region includingEF1hasakey role in inter-
action with the target protein GC (Ermilov, Olshevskaya, & Dizhoor,
2001; Krylov, Niemi, Dizhoor, & Hurley, 1999; Li, Sokal, Bronson,
Palczewski,&Baehr, 2001). EF-hands2–4are fully functional, canon-
ical EF-hand Ca2+-binding sites. Their individual roles have been
explored mostly by site-directed mutagenesis, and recording of
conformational changes in the absence and presence of Ca2+ and/
or Mg2+ (Otto-Bruc et al., 1997; Peshenko & Dizhoor, 2007;
Rudnicka-Nawrot et al., 1998; Sokal et al., 1999).
Pathogenicmutations of residues ﬂanking EF3 and EF4, aswell as
several residues of the EF4 loop of GCAP1, are associated with auto-
somal dominant cone dystrophy (adCD) or autosomal dominant
cone-rod dystrophy (adCRD) (for review: (Baehr & Palczewski,
2007)). Fourmutations are known to affect Ca2+-bindingof EF-hands
(Y99C, I143NT, L151F, E155G) (Dizhoor, Boikov, & Olshevskaya,
1998; Jiang et al., 2005; Nishiguchi et al., 2004; Sokal et al., 1998,
2005; Wilkie et al., 2001). The Y99C mutation is located adjacent
toEF3 (Payneet al., 1998) and I143NTadjacent to theEF4-handmotif
(Nishiguchi et al., 2004). Two mutations (E155G, L151F) are located
in EF4. These mutations alter the dissociation constant and coordi-
nation of Ca2+ to the mutant loop, and change the Ca2+ sensitivity
of GCAP1. As a result, mutant GCAPs are not fully inactivated at dark
Ca2+ levels, leading to the persistent stimulation of GC1 in the dark,
elevated cGMP and Ca2+ levels, and cell death. To date, no naturally
occurring mutations affecting one of the 12 amino acids of the
Ca2+-binding loop of EF3 had been identiﬁed. Here, we investigated
a single familywith dominant cone dystrophy and identiﬁed a novel
mutation in the GUCA1A gene in which Asn-104 (N104), located in
EF3, is replaced by lysine. It is predicted that the N104K substitution
will dramatically affect the ability of the mutant GCAP1 to inhibit
GC1 in dark-adapted cone photoreceptors.Fig. 1. (A) Pedigree of the study family with autosomal dominant cone dystrophy:
Individuals are identiﬁed by pedigree number. Squares indicate males; circle,
females; slashed symbols, deceased; solid symbols, affected; open symbols,
unaffected; +/+, two copies of wild-type; M/+, one copy of wild-type, one copy of
mutant. (B–D) Fundus photos of the posterior pole of the left eye of patient # 4940
at two separate visits, seven years apart. In June of 2000a Topcon 50 degree camera
was used with Kodak Ektachrome 100 ﬁlm and later digitized (B). In April of 2007, a
Canon camera with EMI digital capturing system was used to take color posterior
pole at 60 (C) and a ‘‘red-free” image at 40 for better contrast of the macular
changes (D). (E) Fundus photo of the posterior pole in patient # 8279 taken with
Canon camera. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)2. Methods
2.1. Patients and mutation identiﬁcation
This study was approved by each Institutional Review Board of
the University of Utah Hospitals and Clinics, and the University of
Texas SouthwesternMedical Center-Dallas. All subjects provided in-
formed consent prior to participation. Some subjects underwent
complete ophthalmologic examination including visual acuitymea-
surements and fundus examinations. Blood samples from two fam-
ily members (#8279 and #4940, Fig. 1) were collected under
consignment and genomic DNA was extracted using the Puregene
DNA isolation kit. Each of the four exons of GCAP1 was ampliﬁed
by PCR using ﬂanking intron-speciﬁc primers (GCAP1_exon1F: 50-
GGCCTGTCCATCTCAGACGT; GCAP1_ exon1R: 50-CCCCAGCTGGTC
AGGCTTCCAG; GCAP1_ exon2F: 50-GCCTGAGGCTGGAGTGAGCG;
GCAP1_ exon2R: 50-CTAACCCTGGGCTCTCAGTTCC; GCAP1_exon3F:
50-CCTGAGATAGGATAAGGATGG; GCAP1_exon3R: 50-ACCCCACATC
CATGGTGACC; GCAP1_exon4F: 50-CTGGACTGCAGAAATGAACAC
CCTC; GCAP1_exon4R: 50-GGCGAGCTAAGCCTCTGAGTTC) and
screened formutationsbydenaturinghighperformance liquid chro-
matography (DHPLC; WAVE System, Transgenomic, Omaha, NE).
Sequence alterations were identiﬁed by direct sequencing with a
CEQ Dye Terminator Cycle Sequencing Kit on Beckman-Coulter
CEQ 8000 Genetic Analysis System, according to themanufacturer’s
instructionsandusing establishedmethods (Yanget al., 2005, 2006).
2.2. Electroretinography
Full-ﬁeld ERGs were obtained following ISCEV standards
(Marmor, Holder, Seeliger, & Yamamoto, 2004). Following pupildilation (1% cyclopentolate hydrochloride and 2.5% phenylephrine
hydrochloride) and 45 min dark-adaptation, ERGs were recorded
as detailed (Birch & Fish, 1987). PC-based custom software was
used for stimulus control and timing, data acquisition, averaging,
and analysis.
Inactivation kinetics were probed with the ‘‘paired-ﬂash” para-
digm (Birch, Hood, Nusinowitz, & Pepperberg, 1995), using a test
ﬂash of 2.4 log sc td-s. The paired-ﬂash ERG method involves the
presentation of a bright probe ﬂash at a deﬁned time after the test
ﬂash, and determination of the prevailing response to the test stim-
ulus by analysis of the probe ﬂash response. Underlying the method
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saturation and that the amplitude of the probe-generated ERG
a-wave titrates the prevailing circulating current. The peak ampli-
tude of the probe response as referred to the pre-probe baseline
will approximate the circulating current at time t. From this deter-
mination of the probe response amplitude, and from the maximal
amplitude exhibited by the probe-alone response, one obtains by
subtraction an amplitude A that represents the rod response to
the test ﬂash at time t. That is,
AðtÞ ¼ Amo  AmðtÞ
where Am(t) is the probe response amplitude determined in the
paired-ﬂash trial, Amo is the amplitude of the probe-alone response,
and A(t) is the amplitude at time t of the derived response to the test
ﬂash. We determined the entire time course of the response to the
2.4 log sc td-s ﬂash in two patients (#4940; IV-3 and #8279; IV-1).
2.3. Expression and puriﬁcation of recombinant human GCAP1s
HumanGCAP1 coding sequencewas ampliﬁedbyPCRwithprim-
ers including a 6-histidine tag just before the stop codon, two ﬂank-
ing restriction sites XbaI and XhoI, and then cloned into pFastBac-1.
To generate a N104K point mutation, a site-directed mutagenesis
(QuikChange Site-Directed Mutagenesis Kit, Stratagene) was per-
formed in this hGCAP1 pFastBac construct by using the following
sense and antisense primer: 50-GATGTAGATGGCAAAGGCTGCATT
GACCGCG, 50-CGCGGTCAATGCAGCCTTTGCCATCTACATC. hGCAP1
wild-type and N104K mutant plasmids were transformed into
DH10Bac competent cells to generate the recombinant bacmids,
and then the bacmids were transfected into High ﬁve insect cells
to produce recombinant baculovirus and hGCAP1 proteins (Bac-to-
Bac Baculovirus Expression System, Invitrogen). Expression of the
recombinant hGCAP1swas conﬁrmedbyWestern blot analysiswith
GCAP1 antibody UW101. Recombinant hGCAP1 proteins were puri-
ﬁed with Ni columns (Ni-NTA Columns, Qiagen). The puriﬁed pro-
teins were dialyzed twice for 8–12 h against 2 L of protein buffer
with glycerol (50 mMHEPES, 90 mMKCl, 10 mMNaCl, 50% v/v glyc-
erol, pH7.4) at 4 C.Dialysis of each1 mlaliquotofGCAPpreparation
was performed using a 10 kDa MWCO Slide-A-Lyzer cassetteFig. 2. Standard ISCEV (International Society for Clinical Electrophysiology of Vision) pr
ISCEV standard rod response. (B) The standard combined (rod and cone) ERG response. (C
in the presence of a rod-saturating background. Typical of patients with CD, rod resp
considerable progression.(Pierce) in a cold room. Thepurity and concentration of hGCAP1pro-
teins were estimated by SDS–PAGE with Coomassie blue staining
and Bradford’s protein assay (Bio-Rad).
2.4. SDS–PAGE and limited proteolysis of hGCAP1s
SDS–PAGE in the presence and absence of Ca2+ (1 mM Ca2+ or
1 mM EGTA) and limited proteolysis of puriﬁed GCAP1 and GCAP1
mutants were carried out as described (Nishiguchi et al., 2004;
Rudnicka-Nawrot et al., 1998). For limited proteolysis, the recom-
binant hGCAP1 wild-type or mutant protein in the present or ab-
sence of Ca2+ (1 mM Ca2+ or 1 mM EGTA) was incubated with
trypsin (at a mass ratio of 100:1) at 30 C. Proteolysis of hGCAP1
protein was stopped at various times with trypsin inhibitor (0, 5,
10, 20, 40, and 60 min), and the products were analyzed by SDS–
PAGE with Coomassie staining.
2.5. Recombinant mouse guanylate cyclase 1 and preparation of
washed cell membranes
HEK293 cells stably overexpressing mouse GC1 were plated at
15  106 cells/150 cm2 dish, grown for 48 h, washed twice with
5 ml of protein buffer (50 mM HEPES, 90 mM KCl, 10 mM NaCl,
pH 7.4) with 1 lM leupeptin, and detached by scraping in protein
buffer. The cells were then transferred to 15 ml conical tubes, pel-
leted by centrifugation and after removal of supernatant, snap fro-
zen in liquid N2. To deplete the soluble proteins, each cell pellet
was resuspended in 2 ml of water with 1 lM leupeptin and soni-
cated for 5 s at power level 3 (Branson Soniﬁer 150) followed by
20 min centrifugation at 16,000g. The cell membrane pellet was
resuspended in 150 ll protein buffer with 1 lM leupeptin and
immediately used for GC assay.
2.6. Guanylate cyclase assay
The GC activity was assayed as described (Gorczyca, Van
Hooser, & Palczewski, 1994b; Gorczyca et al., 1994a) with minor
modiﬁcations. Brieﬂy, each 50 ll reaction mix contained 10 ll of
5X assay buffer (150 mM HEPES, 270 mM KCl, 30 mM NaCl,otocol ERGs obtained over a 12-year-period of follow-up in patient # 4940. A, The
) The cone response to a 30 Hz ﬂickering stimulus. (D) The cone response presented
onses remain fairly stable over the follow-up period, while cone responses show
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methyl-xanthine, Sigma), 10 ll of washed cell membranes in pro-
tein buffer (50 mM HEPES, 90 mM KCl, 10 mM NaCl, pH 7.4), 10 ll
of 25 lMwild-type or mutant(N104K) GCAP in protein buffer with
50% v/v glycerol, 5 ll of CaCl2 (concentration ranging from 0.34–
6 mM to obtain free Ca2+ concentration as calculated by computer
program WEBMAXC STANDARD v. 5/21/2007 (Patton, Thompson,
& Epel, 2004)), and 5 ll of nucleotide mix (10 mM GTP, 0.5 lCi
a-33P-GTP). The reaction was initiated by addition of nucleotides,
incubated at 30 C for 10 min and stopped by addition of 15 ll of
0.4 M HCl. Cell membranes were removed by centrifugation at
16,000g for 4 min; the supernatant (40 ll) was transferred to
150 mg of neutral alumina (ICN Biomedicals) in 0.5 ml of
200 mM Tris, 50 mM EDTA, pH 7.4 and vortexed for 8 min. Follow-
ing centrifugation at 16000g for 4 min, the supernatant (0.3 ml)
was mixed with 3 ml of scintillation cocktail and radioactivity
was measured by a scintillation counter.Fig. 3. (A) Paired-ﬂash method in a normal control. Cone responses are computer-
subtracted to isolate the rod photoresponse. When presented singly, the probe-
alone (PA) produces a maximal, saturated response from the rod photoreceptors.
When presented shortly after a just-saturating test ﬂash of 2.4 log sc td-s, the probe
elicits no response as the photoresponse is still saturated. As the interval between
paired-ﬂashes lengthens, the response to the probe becomes evident and progres-
sively grows in amplitude. With an interval of approximately 1500 ms, the response
has fully recovered; i.e., inactivation of the photoresponse is complete. (B) Paired-
ﬂash responses from patient IV:3. (C) Paired-ﬂash responses from patient IV:1.3. Results
3.1. Human patients
The proband (IV-3; #4940) was ﬁrst seen at the Retina Founda-
tion of the Southwest in 1995 at age 33. His acuity was OD 20/200
and OS 20/80. His refraction was OD: 2.00 +3.00  095; OS:
2.00 +3.00  082. He was diagnosed with dominant cone dystro-
phy by the referring retinal specialist. The pedigree (Fig. 1A), fun-
dus appearance (Fig. 1B), and full-ﬁeld ERG (Fig. 2) were all
consistent with the diagnosis. On successive visits, his acuity
dropped to OD: 20/320, OS:20/250 in 2000, OD: 20/400, OS:20/
400 in 2004 and OD: 20/500, OS:20/500 in 2007. Humphrey visual
ﬁelds showed a dense central scotoma which enlarged over time
with near normal sensitivity in the peripheral retina. Visual thresh-
olds 7 below ﬁxation following 45 min of dark-adaptation were
elevated 0.1 log unit in 1995, within normal limits in 2000 and
2004 and elevated 0.1 log unit in 2007.
The proband’s brother (IV-1; #8279) was ﬁrst seen at age 47.
His acuity was OD 20/320 and OS 20/200. His refraction was OD:
5.00 +3.75  113; OS: 3.50 +2.00  077. Humphrey visual ﬁelds
showed a dense central scotoma with near normal sensitivity in
the peripheral retina. Visual thresholds 7 below ﬁxation following
45 min of dark-adaptation were within the normal range.
3.2. Electroretinography
Full-ﬁeld ERGs from the proband are shown in Fig. 2. Rod re-
sponses to the ISCEV standard stimulus (Fig. 2A) were reduced
40% in amplitude compared to the lower limit of normal, and bor-
derline delayed in b-wave implicit time (89.6 ms vs. upper limit of
normal of 88.2 ms). Similarly, mixed rod and cone combined ERGs
were reduced 40% in amplitude (compared to the lower limit of
normal (Fig. 2B). Cone responses to the 30 Hz ﬂicker (Fig. 2C) were
reduced 65% in amplitude compared to the lower limit of normal.
With a b-wave implicit time of 34.4 ms, these responses were only
slightly delayed relative to the upper limit of normal (31.5 ms).
Similarly, the single-ﬂash cone ERG (Fig. 2D) was 70% reduced in
amplitude and borderline normal in b-wave implicit time. Over
12 years of follow-up, rod responses ﬂuctuated somewhat in
amplitude but showed no clear trend toward progression. Cone re-
sponses, on the other hand, declined progressively over the 12
years, but at a slow rate of 0.66 lV (5%) per year.
The brother of the proband (IV-1, #8279) was tested once at age
47 years. His ISCEV standard rod response was reduced in ampli-
tude by 76%, while cone responses to 30 Hz ﬂicker and single-
ﬂashes were reduced in amplitude by greater than 99% (resultsnot shown). Both rod and cone responses were borderline delayed
in b-wave implicit time.
Results from the paired-ﬂash paradigm are shown in Fig. 3 for a
representative normal subject (3A), the proband (3B), and his
brother (3C). The trace marked PA represents the ﬁrst 20 ms of
the maximal, saturated rod response to a probe ﬂash of 4.3 log sc
td-s (log scotopic troland-seconds) presented singly to the dark-
adapted eye. When presented shortly after a just-saturating test
ﬂash of 2.4 log sc td-s, no response to the probe is detected as
the photoresponse is still saturated. The a-wave ﬁrst becomes evi-
dent at about 600 ms in the normal subject, and about 900 ms in
the patients. As the interval between paired-ﬂashes lengthens,
the response to the probe grows in amplitude.
Full recovery functions for the proband (#4940), his brother
(#8279) and the representative normal subject are shown in Fig. 4.
Relative amplitude [the ratio of A to maximum saturated amplitude
(Amo)] is plotted as a function of the time (t) between the test ﬂash
and the probe ﬂash. The best-ﬁt curves are exponential recovery
functions: A/Amo = exp[(tTsat)/s], where Tsat is the period of rod
saturation that precedes recovery and s is a recovery time constant.
Fig. 4. Recovery functions derived from responses shown in Fig. 3A (patient IV:3,
ﬁlled circles), Fig. 3B (patient IV:1, triangles), and Fig. 3C (normal control, open
circles). Open circles (control), the amplitude of each photoresponse is measured at
a ﬁxed time following the probe ﬂash. Relative amplitude is the ratio of A to
maximum saturated amplitude (Amo). The dotted curve is an exponential recovery
function: A/Amo = exp[-(t-Tsat)/s], where Tsat is the period of rod saturation that
preceded recovery and s is a recovery time constant. Filled circles, recovery function
from patient IV:3. Filled triangles, recovery function from patient IV:1. Note the
delay in Tsat for each patient (#4940 = 889 ms; #8279 = 802 ms) compared to the
normal control (Tsat = 520 ms). Mean normal (based on 10 normal subjects) for Tsat
is 490.1 ms, with s.d. = 111.2 ms.
Fig. 5. (A) DNA sequences of the affected individual IV:3 (top) and a normal control
(bottom) showing a C–A transversion in exon 2 of GUCA1A, resulting in a Asp to Lys
change (N104K) in the EF3-hand of GCAP1. (B) Location of N104 in EF3. Binding of
Ca2+ to this loop contributes in switching GCAP1 from the inhibited to the activated
state. (C) The structure of myristoylated chicken GCAP1 showing the arrangement
of the four EF-hands and the position of mutant amino acids homologous to the
human sequence. The structure was drawn with Pymol software based on the 2.0 A
resolution crystal structure (Stephen et al., 2007). Amino acids mutated in
autosomal dominant cone dystrophy are indicated in red. The Y99C mutation is
located adjacent to the EF3-hand motif (Payne et al., 1998) and three mutations
(I143NT, E155G, L151F) have been described in EF4-hand motif (Jiang et al., 2005;
Nishiguchi et al., 2004; Sokal et al., 2005; Wilkie et al., 2001). A ﬁfth mutation
(P50L) is located between EF1 and EF2, and does not affect Ca2+ binding (Newbold et
al., 2001). The N-terminal myristoyl side chain, buried in the N-terminal domain, is
shown in purple in close proximity to the C-terminal helix.
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mean normal of 490.1 ± 111.2 ms (Kozma et al., 2005), both the pro-
band (889 ms) and his brother (802 ms) showed large delays.
3.3. Identiﬁcation of the mutation in the GUCA1A gene
Mutation screening by DHPLC (denaturing high pressure liquid
chromatography) and direct sequencing of ampliﬁed GUCA1A
exons of patient IV:3 identiﬁed a novel C312A transversion in exon
2 (Fig. 5A). This mutation replaced N104 in GCAP1 with Lys result-
ing in a novel N104K change in the GCAP1 amino acid sequences in
the affected individual. No mutation was identiﬁed in exon 2 of
over 200 normal controls. The N104K mutation occurs within the
third EF-hand domain of GCAP1 and represents the ﬁrst naturally
occurring mutation in this 12-amino-acid-loop (Fig. 5B). A muta-
tion of a residue ﬂanking EF3 (Y99C) disrupts the N-terminal helix
of the helix-loop-helix conformation of EF3, severely affecting Ca2+
binding at this site. Another pathogenic mutation of a ﬂanking
hydrophobic residue (I143NT) (Nishiguchi et al., 2004) was ob-
served in EF4, emphasizing the importance of an intact N-terminal
helix for Ca2+ binding. Other mutations linked to cone dystrophy
(E155G, and L151F) affect exclusively Ca2+ coordination in EF4
(Jiang et al., 2005; Sokal et al., 2005; Wilkie et al., 2001) (Fig. 5B).
3.4. Ca2+-dependent conformational changes in wild-type and mutant
GCAP1
N104, the 5th amino acid residue of the EF3 loop, provides a
key ligand for Ca2+ coordination. The N104K mutation is pre-
dicted to severely weaken Ca2+-binding in EF3 since it introduces
a positively charged amino acid destroying Ca2+ coordination of
the amide side chain of Asn. To verify the effects of N104K on
Ca2+-binding, we analyzed recombinant GCAP1(N104K) by two
biochemical methods, mobility shift in denaturing polyacryl-
amide gels in the presence and absence of Ca2+, and susceptibil-
ity to proteolysis in the Ca2+-free state. Ca2+-binding proteins of
the calmodulin superfamily undergo characteristic conforma-
tional changes and shifts in mobility in SDS gels, depending on
the state of Ca2+ coordination. In its Ca2+-free form, GCAP1 mi-
grates slower than the Ca2+-bound form most likely based onconformational changes. As shown in Fig. 6A, wild-type Ca2+-free
GCAP1 displays an apparent mobility of nearly 30 kDa while
Ca2+-bound GCAP1 migrates like a 23 kDa protein, corresponding
to its calculated molecular mass. Recombinant GCAP1(N104K)
showed a Ca2+-shift very similar to the Ca2+-free form regardless
of high or low [Ca2+], an effect that is in contrast to GCAP1(Y99C)
whose Ca2+/EGTA shifts are identical to WT GCAP1 (Sokal et al.,
1998).
We showed previously that, in the absence of Ca2+, GCAP1 is
readily susceptible to proteolysis by trypsin (Rudnicka-Nawrot et
al., 1998; Sokal et al., 2005), presumably by exposing positively
charges residues (sites of trypsin cleavage). Exposure of GCAP1 to
trypsin in the absence of Ca2+ leads to complete digestion in less
than 10 min (Fig. 6B). Proteolysis is restricted, however, when
Ca2+ is bound to the EF-hands because cleavage sites become more
inaccessible owing to conformational changes (Fig. 6C). In contrast
to wild-type GCAP1, GCAP1(N104K) is more susceptible to proteol-
ysis even at 1 mM Ca2+. We conclude that the N104K mutation
introduces a structural change that is irreversible even at 1 mM
Ca2+.
Fig. 6. (A) Ca2+-dependent mobility shift of wild-type GCAP1 (N) and
GCAP1(N104K) (M) recombinant proteins. Coomassie blue staining SDS–PAGE gel
of GCAP1, GCAP1(N104K) in the presence or absence of Ca2+. (B and C) Limited
proteolysis of GCAP1 and of GCAP1(N104K) by trypsin in the presence and absence
of Ca2+. The digestions were performed at 30 C at ratio of GCAP1/trypsin 100:1, and
the digest was analyzed by SDS–PAGE at 0, 5, 10, 20, 40, and 60 min.
Fig. 7. GC stimulation by wild-type versus mutant GCAP1. The effect of wild-type
GCAP1 and GCAP1(N104K) on GC activity. (A) The effect of increasing amounts of
wild-type GCAP1 (d, j) and GCAP1(N104K) (s, h) on GC activity in washed
membranes of HEK293 cells overexpressing GC1. The free Ca2+ concentration was
50 nM. (B) The calcium titration of wild-type GCAP1- or GCAP1(N104K)-mediated
GC1 activity. The GC1 activity was assayed in washed cell membranes of HEK293
cells overexpressing GC1 in the presence of 5 lM wild-type GCAP1 (d) or
GCAP1(N104K) (s) and varying free Ca2+ concentrations set by Ca2+/EGTA buffering
(Section 2). The experiments were performed in triplicate. Error bars are standard
deviation.
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We next compared the ability of GCAP1(N104K) and wild-type
GCAP1 to stimulateGC1 in vitro (Fig. 7).wild-typeandmutantGCAPs
were assayed for GC1 stimulation in the presence of variable
amounts on GCAP1 (Fig. 7A), as well as a function of free Ca2+ (Fig.
7B). The speciﬁc activity of the mutant GCAP1 is signiﬁcantly re-
duced relative towild-type (Fig. 7A) suggesting that themutationaf-
fects GCAP1-GC1 interactions (see Section 4). Previous analyses of
GCAP1 EF-hand loop or ﬂanking mutations (Dizhoor et al., 1998;
Nishiguchi et al., 2004; Sokal et al., 1998, 2005; Wilkie et al., 2001)
showed incomplete inactivation of GC1 at physiological dark Ca2+
levels present in dark-adapted photoreceptors. As shown in Fig.
7B, GCAP1(N104K) is active at low [Ca2+] with a peak activity at
200 nM [Ca2+], dropping to about 60% at very lowCa2+ (10 nM).With
increasing free [Ca2+], the mutant GCAP1 remains active at Ca2+ lev-
els at which wild-type GCAP1 is inactive. Consistent with other EF-
hand mutations, the ﬁndings indicate that mutations affecting EF3
will partially impair GC inhibition, leading to persistent stimulation
in dark-adapted photoreceptors, and raising [cGMP] to toxic levels.
4. Discussion
Heterogeneous cone and cone-rod dystrophies (CD and CRD,
respectively), inherited in a dominant, recessive, or X-linkedfashion, are rare diseases characterized primarily by progressive
dysfunction of the cone-mediated visual system. Major hallmarks
are photophobia, reduced central visual acuity, achromatopsia,
but initially preserved peripheral vision mediated by rod photore-
ceptors (Hamel, 2007; Simunovic & Moore, 1998). CD and CRD are
diagnosed mainly on the basis of changes in the photopic and sco-
topic electroretinogram, but also by fundoscopy and optical coher-
ence tomography (Baraas et al., 2007; Jiang et al., 2005; Wissinger
et al., 2008;Wolﬁng, Chung, Carroll, Roorda, &Williams, 2006). The
best characterized genes linked to dominant CD/CRD are GUCY2D,
encoding photoreceptor guanylate cyclase 1 (retGC-1 or GC1),
and GUCA1A, encoding the Ca2+-binding protein GCAP1, which
are both expressed exclusively in photoreceptors (Palczewski et
al., 2004; Perrault et al., 2000).
The phenotypes of the two patients from the GCAP1(N104K)
family are comparable to other patients with CD. In young patients,
the rod ERG can be normal. Both patients reported here had devel-
oped dense central scotomas, which is typical of the disease and
can modestly affect the rod ERG. Nevertheless, rod function in
the periphery remained normal in both patients on all visits.
Table 1
Genetic loci associated with dominant cone dystrophies
Locus Symbol OMIM Gene Function Reference
6p21.1 CORD3 602093 GUCA1A Guanylate cyclase activator Review: Baehr and Palczewski (2007)
6q13 CORD7 603649 RIMS1 Function unknown; ribbon synapse-associated Johnson et al. (2003)
17p13.1 CORD6 601777 GUCY2D Photoreceptor guanylate cyclase Perrault et al. (1996); review:
Baehr and Palczewski (2007)
17p13.2 CORD5 600977 PITPNM3 involved in photoreceptor membrane renewal;
Drosophila homolog is retinal degeneration B (rdgB)
Kohn et al. (2007)
17q11.2 604011 UNC119 Function unknown; localizes to rod and cone
cytoplasm and ribbon synapses
Kobayashi et al. (2000)
18q21.1-q21.3 CORD1 600624 QRX Transcription factor Wang et al. (2004)
19q13.3 CORD2 120970 CRX Transcription factor Swain et al. (1997)
Column 1, chromosomal localization. Column 2, disease nomenclature according to RetNet. Column 3, online mendelian inheritance in man (OMIM) nomenclature. Column 4,
gene symbol. Column 5, function of the gene product.
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them from patients with CRD, where rod function shows progres-
sive decline throughout the retina (Birch, Anderson, & Fish, 1999).
The cone ERG was more severely affected than the rod ERG in both
patients and showed progressive decline over 12 years of follow-
up in one patient. Both patients showed substantial increases in
Tsat, the period of rod saturation that precedes recovery from an
intense ﬂash. This delayed recovery in the rod ERG photoreceptor
response has been shown to be analogous to a delay in inactivation
in single photoreceptor responses (Pepperberg, Birch, & Hood,
2000). This delay presumably reﬂects a defect in the ability of
mutant GCAP to respond to the drop in free [Ca2+] following
cGMP-gated channel closure.
Other photoreceptor-speciﬁc genes linked to adCD or adCRD are
CRX, RIM1, PITPNM3, and UNC119 (Table 1). The transcription fac-
tor CRX, a factor essential for the maintenance of mammalian pho-
toreceptors (Freund et al., 1997), regulates the expression of
several outer segment proteins such as visual pigments and arres-
tin. Human RIM1, a putative effector protein for rab3 proteins
which are small GTPases involved in synaptic exocytosis (Johnson
et al., 2003; Wang, Liu, Biederer, & Sudhof, 2002). RIM1 is a protein
localizing to the synaptic ribbon and possibly involved in regula-
tion of glutamate release (Schoch et al., 2002). CRD genes like those
encoding a membrane-associated phosphatidylinositol transfer
protein (PITPNM3), a human homolog of the D. melanogaster rdgB
gene, and UNC119 encoding the retina speciﬁc gene RG4 with a
possible function in synaptic transmission (Kobayashi et al.,
2000) are less well characterized.
Considering the diversity of genes and mutations linked to
dominant CD, mutations in the GUCA1A gene are probably the best
understood in terms of disease mechanism. In these GCAP1 mu-
tants, residues involved in Ca2+ coordination or in stabilization of
the loop structure are replaced by inappropriate amino acids lack-
ing the desired properties. The consequence is inability of the mu-
tant GCAP to assume an inactive conformation at physiological
dark [Ca2+] (500 nM). The crystal structure of GCAP1 with bound
Ca2+ (Stephen et al., 2007) shows a molecule consisting of an N-ter-
minal and C-terminal half, each with a pair of EF-hands, as ex-
pected from molecular modeling (e.g., Fig. 8 in (Sokal et al.,
1999)). The N-terminal half forms a hydrophobic pocket to accom-
modate the myristoyl group attached to Gly-2, which is also con-
tacted by the C-terminal helix stabilizing the link between the
two halves. The N-terminal region, including EF1 which does not
coordinate Ca2+, is thought to be instrumental for interaction with
GCs. Under physiological conditions, the C-terminal half containing
EF3 and EF4 is likely responsible for monitoring cytoplasmic [Ca2+]
and triggering conformational changes that convert the inactive
form into an activator. Introduction of a Trp ﬂuorescent reporter
residue ﬂanking EF3 (Y99W) into GCAP1 andmonitoring Ca2+ bind-ing to EF3 revealed a strong conformational change (Km 200 nM)
suggesting that binding of Ca2+ to EF3 may be instrumental in
forming the GC-activator. Tyr99 is a hydrophobic amino acid that
does not distort the helix N-terminal to EF3. However, replacement
of Y99 by a Cys residue (Y99C), the ﬁrst mutation in GCAP1 linked
to dominant cone dystrophy, had adverse effects on the structure
of EF3 and Ca2+-binding (Dizhoor et al., 1998; Sokal et al., 1998).
N104 occupies a position in the EF3 loop that is critical for Ca2+
coordination by providing oxygen of the amide side chain for coor-
dination. Both Y99C and N104K likely weaken Ca2+ coordination at
EF3 under physiological conditions preventing formation of the
Ca2+ bound structure that is essential for inhibiting GC catalytic
activity. The GCAP1 crystal structure implies that mutations in
EF3 may distort contacts of the kinked C-terminal helix with the
N-terminal helix of GCAP1.Acknowledgments
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